logo
Select company
Select metric
Ticker Information

Ticker

SLRX

Company Name

SALARIUS PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SALARIUS PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SLRX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -5.1M0%$ 0
3/31/2025$ -5.57M0%$ 0
12/31/2024$ -5.58M0%$ 0
9/30/2024$ -4.99M0%$ 0
6/30/2024$ -6.46M0%$ 0
3/31/2024$ -8.92M0%$ 0
12/31/2023$ -12.54M0%$ 0
9/30/2023$ -17.92M0%$ 0
6/30/2023$ -29.96M0%$ 0
3/31/2023$ -30.84M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for SALARIUS PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -7.45M ] / Revenues [ $ 4.79M ]
(=) EBIT % [ -155.35% ]

SLRX - EBIT Margin, Last 5 years

-2980.29%

Minimum

Mar 31, 2022

-132.48%

Maximum

Mar 31, 2021

-656.49%

Average

-178.9%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%